Method for producing glycoside compound

By reacting glycoside compounds under specific halogenating agents and solvent conditions, the problem of insufficient purity of glycoside compounds in the prior art is solved, and high-purity glycoside compounds are prepared, which is suitable for oligonucleic acid synthesis.

CN114502567BActive Publication Date: 2024-11-19SUMITOMO CHEM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080070122.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-10-08
Filing Date
2020-08-28
Publication Date
2024-11-19
Estimated Expiration
2040-08-28

AI Technical Summary

Technical Problem

The purity of the glycoside compounds produced in the prior art is not necessarily satisfactory, and it is difficult to effectively inhibit the generation of impurities in the oligonucleic acid synthesis raw materials.

Method used

In the presence of a halogenating agent selected from the group consisting of halogen, N-halosuccinimide and N-halogenated hydantoin, tetrahydropyran or 4-methyltetrahydropyran is used as a solvent to make formula (1) ) is reacted with the ether compound of formula (2) to prepare a high-purity glycoside compound.

Benefits of technology

This method can significantly inhibit the generation of impurities of glycoside compounds, improve the purity of oligonucleic acid synthesis raw materials, and is suitable for synthesis of oligonucleic acids.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114502567B_ABST
    Figure CN114502567B_ABST
Patent Text Reader

Abstract

The object of the present invention is to provide a method for producing a high-purity glycoside compound. a represents an adenine group which may be substituted with an acyl group, i-Pr represents an isopropyl group) and a glycoside compound of formula (2) (wherein R 1 represents a C1-C6 alkyl group or a phenyl group, and n represents 0 or 1) in the presence of one or more halogenating agents selected from the group consisting of halogen, N-halosuccinimide and N-halohydantoin, in at least one solvent selected from the group consisting of tetrahydropyran and 4-methyltetrahydropyran (formula (3)) (wherein, B a , i-Pr and n are as defined above). #imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This patent application claims priority and benefits under the Paris Convention based on Japanese Patent Application No. 2019-185109 (filed on October 8, 2019), and all the contents described in the above application are incorporated into this specification by reference.

[0002] RNA is a ribose-containing nucleic acid oligomer and is a useful material that can be used as an RNA probe, antisense RNA, ribozyme, siRNA, aptamer, and the like. Background Art

[0003] As a method for producing a nucleic acid oligomer, a phosphoramidite compound of a nucleoside in which the hydroxyl group at the 3' position of a nucleoside is phosphoramidated is used. In addition, as a precursor of the phosphoramidite compound of a nucleoside, a glycoside compound in which the hydroxyl group at the 3' position and the hydroxyl group at the 5' position of a nucleoside are substituted with a protecting group and the hydroxyl group at the 2' position is substituted with a protecting group that can be removed under mild conditions is known.

[0004] As a method for producing such a glycoside compound, there is known a method for producing a glycoside compound having an ether derivative group introduced into the 2'-hydroxyl group by reacting a glycoside compound in which the 3'-hydroxyl group and the 5'-hydroxyl group are protected by silicon protecting groups with a thioether compound in tetrahydrofuran as a solvent (Patent Documents 1 and 2).

[0005] Prior art literature

[0006] Patent Literature

[0007] Patent Document 1: Japanese Patent No. 5168145

[0008] Patent Document 2: International Publication No. 2016 / 159374 Summary of the invention

[0009] Problems to be solved by the invention

[0010] The purity of the glycoside compound of the following formula (3) produced by the methods of Patent Documents 1 and 2 is not necessarily satisfactory. An object of the present invention is to provide a method for producing a high-purity glycoside compound.

[0011] Means for solving problems

[0012] The present invention provides a method for producing the following glycoside compound. The present invention includes the embodiments described in the following items, but is not limited thereto.

[0013] Item 1. A method for producing a glycoside compound of formula (3) (hereinafter referred to as "the production method of the present invention"), characterized in that a glycoside compound of formula (1) and an ether compound of formula (2) are reacted in the presence of one or more halogenating agents selected from the group consisting of halogen, N-halosuccinimide and N-halohydantoin, in at least one solvent selected from the group consisting of tetrahydropyran and 4-methyltetrahydropyran.

[0014] [Chemical formula 1]

[0015]

[0016] (In formula (1), B a represents an adenine group which may be substituted with an acyl group, and i-Pr represents an isopropyl group. );

[0017] [Chemical formula 2]

[0018]

[0019] (In formula (2), R 1 represents a C1-C6 alkyl group or a phenyl group, and n represents 0 or 1. );

[0020]

[0021] (In formula (3), B a , i-Pr and n are as defined above. ).

[0022] Item 2. The production method according to Item 1, wherein n is 1.

[0023] Item 3. The production method according to Item 1, wherein n is 0.

[0024] Item 4. The production method according to any one of Items 1 to 3, wherein the halogenating agent is a halogen.

[0025] Item 5. The production method according to any one of Items 1 to 4, wherein the halogenating agent is iodine.

[0026] Item 6. The production method according to any one of Items 1 to 5, wherein R 1 It is methyl.

[0027] Item 7. The production method according to any one of Items 1 to 6, wherein B a It is an adenine group substituted by an acetyl group or a benzoyl group.

[0028] Item 8. The production method according to any one of Items 1 to 6, wherein B a It is an adenine group substituted by an acetyl group.

[0029] Effects of the Invention

[0030] According to the production method of the present invention, the generation of impurities of a glycoside compound as a raw material for oligonucleic acid synthesis can be suppressed. The glycoside is suitable for oligonucleic acid synthesis. DETAILED DESCRIPTION

[0031] Hereinafter, the present invention will be described in detail.

[0032] Furthermore, the term “comprise” in the specification also includes the meanings of “essentially consist of” and “consist only of”.

[0033] A method for producing a glycoside compound of formula (3) (hereinafter referred to as "the method of the present invention") is described, which is characterized in that a glycoside compound of formula (1) and an ether compound of formula (2) are reacted in the presence of one or more halogenating agents selected from the group consisting of halogen, N-halosuccinimide and N-halohydantoin, in at least one solvent selected from the group consisting of tetrahydropyran and 4-methyltetrahydropyran.

[0034] In the glycosides of formula (1) and formula (3), B a The adenine group which may be substituted with an acyl group represented by has the following structure.

[0035] [Chemical formula 4]

[0036]

[0037] (Where R 2 represents a hydrogen atom or an acyl group. )

[0038] The acyl group represents a straight-chain or branched aliphatic acyl group or an aromatic acyl group, and the total number of carbon atoms including the carbon atom of the carbonyl group is 2 to 12, preferably the number of carbon atoms is 2 to 7. Examples of the acyl group include aliphatic acyl groups (for example, acetyl, propionyl, butyryl (butanoyl / butyryl group), isobutyryl (isobutanoyl / isobutyryl group), valeryl, hexanoyl, heptanoyl, octanoyl, nonanoyl, decanoyl and undecanoyl), and aromatic acyl groups (for example, benzoyl, 1-naphthoyl and 2-naphthoyl), and preferably acetyl or benzoyl.

[0039] As the halogenating agent, for example, halogens such as iodine and bromine; N-halosuccinimides such as N-chlorosuccinimide, N-bromosuccinimide (NBS) and N-iodosuccinimide (NIS); N-halohydantoins such as 1,3-diiodo-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin and 1-bromo-3-chloro-5,5-dimethylhydantoin. In the present invention, halogens are preferably used, and iodine is more preferably used.

[0040] For the reaction of the present invention, in addition to the halogenating agent, an acid can be added and implemented. As an acid, for example, perfluoroalkyl carboxylic acids and salts thereof, alkyl sulfonic acids and salts thereof, aryl sulfonic acids and salts thereof, perfluoroalkyl sulfonic acids and salts thereof, alkyl sulfonic acids and salts thereof, and combinations of two or more thereof can be cited. As a salt, for example, metal salts (for example, copper salts and silver salts) can be cited. As an acid, specifically, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, trifluoromethanesulfonic acid and silver trifluoromethanesulfonate, etc., and combinations of two or more thereof can be cited. The alkyl group of the alkyl sulfonic acid can be any of linear or branched, preferably an alkyl group with 1 to 6 carbon atoms. As an alkyl group, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl and hexyl can be cited. As an aryl group of an aryl sulfonic acid, for example, phenyl and tolyl can be cited.

[0041] In the ether compound of formula (2), R 1 The alkyl group represented by may be straight chain or branched, and preferably has 1 to 6 carbon atoms. Examples of the alkyl group include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, and hexyl. The alkyl group is preferably methyl.

[0042] As the solvent for the reaction of the present invention, tetrahydropyran compounds can be mentioned, and specifically tetrahydropyran (THP) or 4-methyltetrahydropyran (MTHP) or a mixed solvent thereof can be used. The amount of the solvent is usually 0.5 v / w to 20 v / w%, preferably 1 v / w to 10 v / w%, relative to the glycoside compound represented by formula (1).

[0043] The amount of the ether compound represented by formula (2) is usually 0.8 to 5 mol, preferably 1 to 3 mol, and more preferably 1 to 1.5 mol, relative to 1 mol of the glycoside compound represented by formula (1). The amount of the halogenating agent is usually 0.8 to 10 mol, preferably 3 to 10 mol, and more preferably 3 to 6 mol, relative to 1 mol of the glycoside compound represented by formula (1). The amount of the acid is usually 0 to 5 mol, preferably 0 to 1.5 mol, and more preferably 0 to 0.1 mol, relative to 1 mol of the glycoside compound represented by formula (1).

[0044] The reaction temperature of the present invention is usually -30 to 30° C., preferably -20 to 25° C., more preferably -15 to 5° C. The reaction time of the present invention is usually 0.5 to 10 hours, preferably 0.5 to 6 hours.

[0045] The glycoside compound represented by formula (1) can be produced by a known method or a commercial product can be purchased. The ether compound represented by formula (2) can be produced by a known method (Patent Documents 1 and 2 and Japanese Patent Application Publication No. 2016-50203).

[0046] The glycoside compound obtained in the present invention may be used in the next reaction as a crude product, but may also be purified by silica gel column chromatography or the like as necessary.

[0047] Example

[0048] Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples and the like.

[0049] The purity of the synthesized glycoside compound was measured by HPLC. The components of the glycoside compound were separated by HPLC, and the sum of the area percentages of the by-products in the obtained chromatogram was calculated as the amount of the by-products. The HPLC device used was set to detect peaks with an area value of more than 1000, and the peak with the minimum area value that could be detected under these conditions was 0.03% by area percentage.

[0050] [Table 1]

[0051]

[0052] Hereinafter, in this specification, CEM represents a 2-cyanoethoxymethyl group, and EMM represents a 2-cyanoethoxymethoxymethyl group.

[0053] Example 1

[0054] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-2'-O-(2-cyanoethoxymethoxymethyl)adenosine (EMM A)

[0055] [Chemical formula 5]

[0056]

[0057] N 6-Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine (1.0 g, 1.8 mmol) was dissolved in 4-methyltetrahydropyran (10 ml), and the mixture was cooled to 0°C. Methanesulfonic acid (17 mg, 0.18 mmol), iodine (2.7 g, 10.8 mmol) and 2-cyanoethoxymethylmethylthiomethyl ether (0.44 g, 2.7 mmol) were added thereto, and the mixture was stirred at 0°C for 3 hours under a nitrogen atmosphere. The reaction solution was added to a mixed solution of a saturated sodium thiosulfate aqueous solution and a saturated sodium bicarbonate aqueous solution, and extracted with ethyl acetate. The solvent was distilled off to obtain a crude product containing the target compound.

[0058] As a result of HPLC analysis, the total LC area percentage of the by-products was 5.9%.

[0059] Example 2

[0060] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-2'-O-(2-cyanoethoxymethyl)adenosine (CEM A)

[0061] [Chemical formula 6]

[0062]

[0063] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine (1.0 g, 1.8 mmol) was dissolved in 4-methyltetrahydropyran (5 ml), and the mixture was cooled to 0°C. Methanesulfonic acid (17 mg, 0.18 mmol), iodine (2.7 g, 10.8 mmol) and methylthiomethyl 2-cyanoethyl ether (0.35 g, 2.7 mmol) were added thereto, and the mixture was stirred at 0°C for 3 hours under a nitrogen atmosphere. The reaction solution was added to a mixed solution of a saturated sodium thiosulfate aqueous solution and a saturated sodium bicarbonate aqueous solution, and extracted with ethyl acetate. The solvent was distilled off to obtain a crude product containing the target compound.

[0064] As a result of HPLC analysis, the total LC area percentage of the by-products was 3.3%.

[0065] Example 3

[0066] N 6-Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-2'-O-(2-cyanoethoxymethoxymethyl)adenosine (EMM A)

[0067] [Chemical formula 7]

[0068]

[0069] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine (5.0 g, 9.0 mmol) was dissolved in toluene (25 ml), and the solution was concentrated to 15 ml. 4-Methyltetrahydropyran (10 ml) was added to the solution, and the mixture was cooled to -10°C. Iodine (13.8 g, 55.2 mmol) and 2-cyanoethoxymethylmethylthiomethyl ether (2.18 g, 13.4 mmol) were added thereto, and the mixture was stirred at 0°C for 1 hour under a nitrogen atmosphere. The reaction solution was added to a mixed solution of a saturated sodium thiosulfate aqueous solution and a saturated sodium bicarbonate aqueous solution, and extracted with toluene. The solvent was distilled off to obtain a crude product containing the target compound.

[0070] As a result of HPLC analysis, the total LC area percentage of the by-products was 7.1%.

[0071] Comparative Example 1

[0072] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-2'-O-(2-cyanoethoxymethoxymethyl)adenosine (EMM A)

[0073] [Chemical formula 8]

[0074]

[0075] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine (1.0 g, 1.8 mmol) was dissolved in tetrahydrofuran (10 ml), and the mixture was cooled to 0°C. Methanesulfonic acid (17 mg, 0.18 mmol), iodine (2.7 g, 10.8 mmol) and 2-cyanoethoxymethyl methylthiomethyl ether (0.44 g, 2.7 mmol) were added thereto, and the mixture was stirred at 0°C for 3 hours under a nitrogen atmosphere. The reaction solution was added to a mixed solution of a saturated sodium thiosulfate aqueous solution and a saturated sodium bicarbonate aqueous solution, and extracted with ethyl acetate. The solvent was distilled off to obtain a crude product containing the target compound.

[0076] As a result of HPLC analysis, the total LC area percentage of the by-products was 10.2%.

[0077] Comparative Example 2

[0078] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-2'-O-(2-cyanoethoxymethyl)adenosine (CEM A)

[0079] [Chemical formula 9]

[0080]

[0081] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine (1.0 g, 1.8 mmol) was dissolved in tetrahydrofuran (5 ml), and the mixture was cooled to 0°C. Methanesulfonic acid (17 mg, 0.18 mmol), iodine (2.7 g, 10.8 mmol) and methyl methylthio 2-cyanoethyl ether (0.35 g, 2.7 mmol) were added thereto, and the mixture was stirred at 0°C for 3 hours under a nitrogen atmosphere. The reaction solution was added to a mixed solution of a saturated aqueous sodium thiosulfate solution and a saturated aqueous sodium bicarbonate solution, and extracted with ethyl acetate. The solvent was distilled off to obtain a crude product containing the target compound.

[0082] As a result of HPLC analysis, the total LC area percentage of the by-products was 8.6%.

[0083] Comparative Example 3

[0084] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-2'-O-(2-cyanoethoxymethoxymethyl)adenosine (EMM A)

[0085] [Chemical formula 10]

[0086]

[0087] N 6 -Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine (5.0 g, 9.0 mmol) was dissolved in toluene (25 ml), and the solution was concentrated to 15 ml. Tetrahydrofuran (10 ml) was added to the solution, and the mixture was cooled to -10°C. Iodine (13.8 g, 55.2 mmol) and 2-cyanoethoxymethyl methylthiomethyl ether (2.18 g, 13.4 mmol) were added thereto, and the mixture was stirred at 0°C for 1 hour under a nitrogen atmosphere. The reaction solution was added to a mixed solution of a saturated sodium thiosulfate aqueous solution and a saturated sodium bicarbonate aqueous solution, and extracted with toluene. The solvent was distilled off to obtain a crude product containing the target compound.

[0088] As a result of HPLC analysis, the total LC area percentage of the by-products was 10.7%.

[0089] The test results of the above-mentioned examples and comparative examples are shown in Table 2.

[0090] [Table 2]

[0091]

[0092] As shown in Table 2 above, by using 4-methyltetrahydropyran (MTHP) as a solvent, the generation of by-products can be suppressed, thereby obtaining the target product with higher purity.

[0093] Industrial Applicability

[0094] The present invention provides a method for producing a glycoside compound. The glycoside compound obtained by the production method has high purity and is therefore suitable for use in the synthesis of high-purity oligonucleic acid.

Claims

1. A method for producing a glycoside compound of formula (3), characterized in that: The glycoside compound of formula (1) and the ether compound of formula (2) are reacted in 4-methyltetrahydropyran in the presence of iodine. In formula (1), B a represents an adenine group substituted with an acetyl group, and i-Pr represents an isopropyl group; In formula (2), R 1 represents a methyl group, and n represents 0 or 1; In formula (3), B a , i-Pr and n are defined as above.

2. The manufacturing method according to claim 1, wherein: n is 1.

3. The manufacturing method according to claim 1, wherein: n is 0.